Qube Research & Technologies (QRT)
AVBP icon

Qube Research & Technologies (QRT)’s ArriVent BioPharma AVBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70,317
Closed -$1.62M – 4196
2026
Q1 		$1.62M Buy
+70,317
New +$1.59M ﹤0.01% 2275
2024
Q4 		– Sell
-11,354
Closed -$267K – 3873
2024
Q3 		$267K Buy
+11,354
New +$258K ﹤0.01% 2470

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AVBP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of ArriVent BioPharma (AVBP) in Q2 2026, closing a stake of 70,317 shares — an estimated $1.62M sold.

Qube Research & Technologies (QRT) first reported a position in AVBP in Q3 2024 and held it in 2 quarters. The position peaked at $1.62M in Q1 2026. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining ArriVent BioPharma position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 70,317 ArriVent BioPharma shares in Q2 2026, an estimated $1.62M.
  • Qube Research & Technologies (QRT) first reported a position in ArriVent BioPharma in Q3 2024 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s ArriVent BioPharma position peaked at $1.62M in Q1 2026.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.